Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Lisspers (Uppsala, Sweden), M. Hogman (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), H. Hedenstrom (Uppsala, Sweden), K. Broms (Uppsala, Sweden), B. Stallberg (Uppsala, Sweden). COPD patients with asthma, characteristics and risk of exacerbations. 5017

Member's Comments

No comment yet.

Related content which might interest you: The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 COPD exacerbations and predictors in a general population Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 The frequency of COPD exacerbations is related to the comorbidity profile Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013